Cargando…

Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate

PURPOSE: To evaluate the outcomes of ruthenium-106 ((106)Ru) brachytherapy in terms of radiation parameters in patients with thick uveal melanomas. MATERIAL AND METHODS: Medical records of 51 patients with thick (thickness ≥ 7 mm and < 11 mm) uveal melanoma treated with (106)Ru brachytherapy duri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naseripour, Masood, Jaberi, Ramin, Sedaghat, Ahad, Azma, Zohreh, Nojomi, Marzieh, Falavarjani, Khalil Ghasemi, Nazari, Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793070/ https://www.ncbi.nlm.nih.gov/pubmed/26985199 http://dx.doi.org/10.5114/jcb.2016.57818

Ejemplares similares

Ruthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results
por: Mirshahi, Reza, et al.
Publicado: (2022)

Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016)

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)

(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)

Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Naseripour, Masood, et al.
Publicado: (2016)

Short-term changes of cornea and tear film after ruthenium-106 plaque therapy for intraocular tumors
por: Aghaei, Hossein, et al.
Publicado: (2021)

Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017)

Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis
por: Karimi, Saeed, et al.
Publicado: (2021)

Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
por: Tarmann, Lisa, et al.
Publicado: (2017)

Optical coherence tomography angiography (OCTA) applications in ocular oncology
por: Naseripour, Masood, et al.
Publicado: (2020)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Treatment Outcome of Acquired Retinal Pigment Epithelial Tumors with Rhuthenium-106 Plaque Radiotherapy: Experience on Two Cases
por: Naseripour, Masood, et al.
Publicado: (2020)

Outcomes of I-125 brachytherapy for uveal melanomas depending on irradiation dose applied to the tumor apex – a single institution study
por: Kowal, Joanna, et al.
Publicado: (2018)

Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas
por: Ghassemi, Fariba, et al.
Publicado: (2020)

Monosomy 3 by chromogenic in situ hybridization (CISH) in Iranian patients with uveal melanoma
por: Naseripour, Masood, et al.
Publicado: (2015)

Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration
por: Modarreszadeh, Mehdi, et al.
Publicado: (2008)

New Hope for Retinoblastoma Patients
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2010)

Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses
por: Miguel, David, et al.
Publicado: (2018)

A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes
por: Siavashpour, Zahra, et al.
Publicado: (2016)

Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience
por: Mazzini, Cinzia, et al.
Publicado: (2023)

Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma
por: AlMahmoud, Tahra, et al.
Publicado: (2018)

Optical coherence tomography angiography–based analysis of intrinsic vasculature in juxtapapillary melanoma after ruthenium-106 plaque brachytherapy
por: Shanmugam, P Mahesh, et al.
Publicado: (2019)

Retinocytoma associated with bilateral retinoblastoma
por: Naseripour, Masood, et al.
Publicado: (2010)

Ruthenium brachytherapy for iris melanoma
por: Zwolin´ska, Emilia, et al.
Publicado: (2023)

“Inverted Snowing-Cloud” Sign in Endogenous Candida Endophthalmitis
por: Anvari, Pasha, et al.
Publicado: (2022)

Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients
por: Cho, Yeona, et al.
Publicado: (2018)

Adjuvant high-dose-rate brachytherapy in the management of oral cavity cancers: 5 years of experience in Iran
por: Kazemian, Ali, et al.
Publicado: (2017)

High-Dose-Rate (192)Ir Brachytherapy Dose Verification: A Phantom Study
por: Nikoofar, Alireza, et al.
Publicado: (2015)

Vitrectomy for Posterior Segment Intraocular Foreign Bodies, Visual and Anatomical Outcomes
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2013)

The measurement of three dimensional dose distribution of a ruthenium‐106 ophthalmological applicator using magnetic resonance imaging of BANG polymer gels
por: Chan, Maria F., et al.
Publicado: (2001)

Radiobiological evaluation of organs at risk for electronic high-dose-rate brachytherapy in uveal melanoma: a radiobiological modeling study
por: Waldron, Timothy J., et al.
Publicado: (2021)

Stem Cell Therapy in Stargardt Disease: A Systematic Review
por: Moghadam Fard, Atousa, et al.
Publicado: (2023)

Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy
por: Siavashpour, Zahra, et al.
Publicado: (2016)

Double Retina Sign: A New Optical Coherence Tomography Finding in Combined Hamartoma of the Retina and Retinal Pigment Epithelium
por: Naseripour, Masood, et al.
Publicado: (2023)

Evaluation of deformable image registration algorithm for determination of accumulated dose for brachytherapy of cervical cancer patients
por: Mohammadi, Reza, et al.
Publicado: (2019)

Antenatal corticosteroids: a reappraisal of the drug formulation and dose
por: Jobe, Alan H., et al.
Publicado: (2020)

Short term effect of intravitreal bevacizumab for diabetic macular edema associated with epiretinal membrane
por: Maryam, Ashraf Khorasani, et al.
Publicado: (2018)

Perfluorocarbon liquid migration into the subarachnoid space in a patient with morning glory syndrome
por: Naseripour, Masood, et al.
Publicado: (2015)

High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study
por: Kalaghchi, Bita, et al.
Publicado: (2018)

Dosimetric evaluation of a novel high dose rate (HDR) intraluminal / interstitial brachytherapy applicator for gastrointestinal and bladder cancers
por: Tabrizi, Sanaz Hariri, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2e9tgnlid7mm2g6fk6q733ktu5